Friday, July 10, 2026

pharma · Multiple Myeloma · Relapsed/Refractory Multiple Myeloma

Janssen-Cilag International N.V

Janssen-Cilag International N.V events on NovaPharmaNews — congress presentations and investor conference coverage.

São Paulo, EU HQ
13 Employees
EMA registrant Type
Company details
Status
Public
HQ
São Paulo, EU
Employees
13
Programs
161
Drugs
159
Patents
0
Intelligence · Events

Events

Janssen-Cilag International N.V events on NovaPharmaNews — congress presentations and investor conference coverage.

Janssen-Cilag International N.V events on NovaPharmaNews — congress presentations and investor conference coverage.

No linked events yet

Presentation ingest will populate congress and catalyst events for this sponsor.

Back to company overview →